Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Letter Regarding Texas House Bill 2815 (2019) – Requesting Amendments
-
ACMG Letter Regarding Texas Senate Bill 754 (2019) – Requesting Amendments
-
ACMG Letter to Congress Regarding the Advancing Access to Precision Medicine Act
-
ACMG Letter Regarding Pennsylvania House Bills 2618 and 2619 (2018) – Requesting Amendments
-
ACMG Letter Regarding Pennsylvania Senate Bills 1074 and 1169 (2018) – Requesting Amendments
-
ACMG Comments to CMS Concerning CLFS Gapfill Preliminary Determinations for GS Codes 81425, 81426, and 81427
-
ACMG Responds to FDA’s Approval for DTC Testing for Three BRCA Gene Mutations
-
ACMG Letter Regarding South Carolina House Bill 3751 (2017) – Requesting Amendments
-
ACMG Letter Regarding South Carolina Senate Bill 264 (2017) – Requesting Amendments
-
ACMG Response to Expansion of Direct-to-Consumer Genetic Testing